Looking to publish in Inflammopharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowInflammopharmacology is a comprehensive resource on all aspects of inflammation and its pharmacological control, emphasizing pain therapy. It compares different inflammatory states and their causes, examines the actions, therapeutic efficacy and safety of drugs used in the treatment of inflammatory conditions, and covers Conditional Pharmacology/Toxicology, Rheumatology, Gastroenterology, Neuro-Inflammation, and Novel Drugs, Natural Products and Nutraceuticals, with particular emphasis on methods of measurement of clinical response effects of new agents and adverse effects from anti-rheumatic drugs, as well as the safety and efficacy of non-prescription and prescription NSAIDs and analgesics.
Looking to publish in Inflammopharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Inflammopharmacology accepts the following article types. Click on an article type to view submission instructions.
Research
Reviews
Brief Report
Correspondence
Recent Publications
The alkaloid-rich extract of Piper sintenense Hatusima alleviates gouty inflammatory response via Nrf2-mediated antioxidant induction
Zhiren Yao, Yu Su, Yaping Huang, Can Hu, Ke Pan, Jian Zhang, Guoqing Zhao, Lei Wang, Zhiqi Yin
Tau physiology and pathology: impacts on cellular structures and neurodegenerative diseases
Vali Akbari, Seifollah Bahramikia
The methanolic extract of Byrsonima intermedia mitigates colonic injury in experimental colitis through redox restoration, cytokine modulation, and tissue repair
Karla Stella Figueiredo Romano, Felipe Leonardo Fagundes, Quélita Cristina Pereira, Maycon Tavares Emílio-Silva, Larissa Lucena Périco, Vinicius Peixoto Rodrigues, Gabriela Bueno, Mateus Magami Yoshitani, Giovana Pacciulli Pereira, José Aires Pereira, Carlos Augusto Real Martinez, Alessandra Gambero, Clélia Akiko Hiruma-Lima, Raquel de Cássia dos Santos
Phytocompounds with immunomodulatory activities: mechanisms, therapeutic potential, and clinical prospects
Noha A. Mehana, Nourhan Ibrahim Morad, Rehab Mekky, Amal M. Mahfoz, Riham A. El-Shiekh, Mahmoud A. Elrebehy
Febuxostat attenuates chronic kidney disease induced by adenine in rats: role of TLR4/NF-κB/NLRP3/Caspase1/IL-1β pathway
Omnia A. Nour, Mahmoud M. Samaha, Haitham M. Sewilam, Dalia H. El-Kashef
Frequently asked questions
How long does it take to publish?
All manuscripts are reviewed anonymously by at least two independent reviewers. Articles are published online after receipt of the corrected proofs.
Reformat to Inflammopharmacology using Livewrite PremiumIs a cover letter required?
An accompanying letter submitted with the manuscript should state that the paper is original, unpublished, and not under consideration elsewhere. The corresponding author should mention unpublished material included in the manuscript in a cover letter to the editor.
Reformat to Inflammopharmacology using Livewrite PremiumWhat are the publication costs?
Open access APC: £3290.00 GBP / $5290.00 USD / €4090.00 EUR. Subscription publishing is available with no APC.
Reformat to Inflammopharmacology using Livewrite Premium